-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Drotaverine is a phthalic acid ester that is commonly used in the chemical industry as a catalyst in the production of polyurethane foam.
It is also used as a solvent for various industrial applications.
However, the use of Drotaverine has raised concerns about its safety in the workplace and the environment.
One of the main concerns with Drotaverine is its potential to cause cancer.
The International Agency for Research on Cancer (IARC) has classified Drotaverine as a possible human carcinogen, based on evidence that it can cause cancer in animals.
Studies have shown that Drotaverine can cause liver and lung cancer in rats and mice, and there is some evidence to suggest that it may also cause cancer in humans.
Another health concern associated with Drotaverine is its potential to cause reproductive and developmental effects.
Studies in animals have shown that Drotaverine can cause birth defects and can affect the reproductive system.
There is also some evidence to suggest that Drotaverine can cause similar effects in humans.
Drotaverine is also known to be harmful to the environment.
It is classified as a persistent organic pollutant (POP) and can persist in the environment for long periods of time.
This means that it can accumulate in soil, water and fatty tissues of living organisms, including humans and wildlife.
This can lead to the bioaccumulation of Drotaverine in the food chain, which can cause harm to wildlife and potentially to human health.
In addition to its potential health and environmental effects, Drotaverine is also known to be hazardous to handle in the workplace.
It is classified as a Category 2 carcinogen by the National Institute for Occupational Safety and Health (NIOSH), which means that it is suspected of causing cancer in humans.
It is also classified as a severe irritant by the NIOSH, which means that it can cause severe respiratory and skin irritation.
It is also classified as a highly flammable liquid, which means that it can easily catch fire and can cause fires to spread.
To prevent the harm caused by Drotaverine, it is important to take the necessary precautions when handling it in the workplace.
This includes wearing appropriate personal protective equipment ( PPE), such as respirators and gloves, and following proper safety procedures, such as proper storage and disposal of the chemical.
In addition, companies that use Drotaverine in their production processes should ensure that they are following all relevant regulations and guidelines related to its use, handling and disposal.
In conclusion, Drotaverine is a chemical that is commonly used in the production of polyurethane foam and as a solvent in various industrial applications.
However, its potential to cause cancer, reproductive and developmental effects, and environmental harm, make it a chemical of concern.
It is important for companies that use Drotaverine to take the necessary precautions to prevent harm to workers and the environment, and for regulators to continue to monitor its use and impact.